WIXOM, Mich., March 9, 2010 (GLOBE NEWSWIRE) -- Rockwell Medical (Nasdaq:RMTI), a fully-integrated biopharmaceutical company offering innovative products and services targeting end-stage renal disease (ESRD), chronic kidney disease (CKD) and iron deficiency anemia, announced today that it will hold an investor conference call on Wednesday, March 10, 2010 at 4:15 p.m. ET to discuss its fourth quarter and year-end 2009 results. Robert Chioini, Chairman and CEO, Thomas Klema, CFO, and Dr. Richard Yocum, Vice President of Drug Development and Medical Affairs, will be hosting the call to review Rockwell's results. Dr. Ajay Gupta, Chief Scientific Officer, will then join the management team to answer questions from investors about the financial results as well as the Company's recently announced Phase IIb results. Rockwell will be releasing the earnings results on the same date.
